Skip to main content
Signal8

R01 Fund LP

SEC insider (Form 3/4/5 filer). CIK 0001990517. 10% Owner at Stablecoin Development Corp (SDEV). 9 reported Form 4/5 transactions since Sep 2024; latest on Jun 15, 2026. Located in MIAMI BEACH, FL.

Companies R01 Fund LP has filed insider reports for

  • Stablecoin Development Corp (SDEV): 10% Owner
R01 Fund LP profile photo

R01 Fund LP

CIK: 0001990517

Transaction Breakdown

Open Market Buys (P)3 (33.3%)

High conviction signal

Open Market Sales (S)1 (11.1%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (22.2%)

Compensation grants

Other (G, F, J, C, D, …)3 (33.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Stablecoin Development Corp logo
SDEV

Stablecoin Development Corp

10% Owner

Discretionary Trading P&L

Holdings

Transaction History (9 total)

  • Stablecoin Development Corp logo
    SDEV

    Stablecoin Development Corp

    Jun 15, 2026
    Sale
    Direct
    24.7K shares at avg. $1.09$27K
  • Stablecoin Development Corp logo
    SDEV

    Stablecoin Development Corp

    Jun 15, 2026
    In-the-Money
    Direct
    11.3M shares at avg. $0.00$27K
  • Stablecoin Development Corp logo
    SDEV

    Stablecoin Development Corp

    Jan 16, 2026
    Purchase

    Pre-Funded Warrants (Right to Buy)

    Indirect
    53.7M shares at avg. $0.85-
  • Stablecoin Development Corp logo
    SDEV

    Stablecoin Development Corp

    Oct 21, 2025
    Conversion
    Direct
    11.4M shares-
  • NovaBay Pharmaceuticals, Inc. logo
    NBY

    NovaBay Pharmaceuticals, Inc.

    Oct 21, 2025
    Conversion
    Direct
    56.8M shares-
  • Stablecoin Development Corp logo
    SDEV

    Stablecoin Development Corp

    Oct 16, 2025
    Purchase

    Pre-Funded Warrants (Right to Buy)

    Direct
    11.3M shares-
  • NovaBay Pharmaceuticals, Inc. logo
    NBY

    NovaBay Pharmaceuticals, Inc.

    Oct 16, 2025
    Purchase

    Pre-Funded Warrants (Right to Buy)

    Direct
    2.7M shares-
  • NovaBay Pharmaceuticals, Inc. logo
    NBY

    NovaBay Pharmaceuticals, Inc.

    Oct 16, 2025
    Award

    Series E Non-Voting Convertible Preferred Stock

    Direct
    134.4K shares-
  • NovaBay Pharmaceuticals, Inc. logo
    NBY

    NovaBay Pharmaceuticals, Inc.

    Oct 16, 2025
    Award

    Series D Non-Voting Convertible Preferred Stock

    Direct
    220.7K shares-

1-9 of 9